PT-141 (Cat No.:M043676) is a synthetic peptide used for treating hypoactive sexual desire disorder (HSDD) in premenopausal women. It works by activating melanocortin receptors, which are involved in sexual arousal pathways. Unlike other treatments, PT-141 does not target the vascular system but instead acts directly on the central nervous system. This unique mechanism makes it an effective alternative for individuals who do not respond to traditional therapies. Available as a subcutaneous injection, PT-141 offers a promising solution for enhancing sexual desire and improving overall sexual health.
| Catalog Number | M043676 |
| CAS Number | 189691-06-3 |
| Molecular Formula | C50H68N14O10 |
| Purity | 95% |
| Storage | Desiccate at -20C |
| IUPAC Name | (3S,6S,9R,12S,15S,23S)-15-[[(2S)-2-acetamidohexanoyl]amino]-9-benzyl-6-[3-(diaminomethylideneamino)propyl]-12-(1H-imidazol-5-ylmethyl)-3-(1H-indol-3-ylmethyl)-2,5,8,11,14,17-hexaoxo-1,4,7,10,13,18-hexazacyclotricosane-23-carboxylic acid |
| InChI | InChI=1S/C50H68N14O10/c1-3-4-16-35(58-29(2)65)43(67)64-41-25-42(66)54-20-11-10-18-37(49(73)74)60-46(70)39(23-31-26-56-34-17-9-8-15-33(31)34)62-44(68)36(19-12-21-55-50(51)52)59-45(69)38(22-30-13-6-5-7-14-30)61-47(71)40(63-48(41)72)24-32-27-53-28-57-32/h5-9,13-15,17,26-28,35-41,56H,3-4,10-12,16,18-25H2,1-2H3,(H,53,57)(H,54,66)(H,58,65)(H,59,69)(H,60,70)(H,61,71)(H,62,68)(H,63,72)(H,64,67)(H,73,74)(H4,51,52,55)/t35-,36-,37-,38+,39-,40-,41-/m0/s1 |
| InChIKey | FFHBJDQSGDNCIV-MFVUMRCOSA-N |
| SMILES | CCCCC(C(=O)NC1CC(=O)NCCCCC(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)CC2=CN=CN2)CC3=CC=CC=C3)CCCN=C(N)N)CC4=CNC5=CC=CC=C54)C(=O)O)NC(=O)C |
